ARWR

Q: What is the price of Arrowhead Pharmaceuticals (ARWR) today?

The current price of Arrowhead Pharmaceuticals (ARWR) is $ 74.95, representing a 395.37% gain over the past year. The stock began the year trading around $ 66.39 and is currently priced at $ 74.95. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Arrowhead Pharmaceuticals (ARWR) pay dividends?

Arrowhead Pharmaceuticals (ARWR) did not pay dividends over the past year.

Arrowhead Pharmaceuticals Inc.

Price

$ 74.95

return (12m)

395.37%

p/e

-35.37

p/bv

17.77

DIVIDEND YIELD

0.00%

ARWR price

Arrowhead Pharmaceuticals

If you had invested

exposure

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

15 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment ARWR

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

1.41%

3 months

18.70%

1 year

395.37%

2 years

201.25%

5 years

2.01%

10 years

1,172.50%

Fundamentals ARWR

review the fundamentals of Arrowhead Pharmaceuticals shares

P/E

-35.37

Sector: -3.84 Industry: -3.84

P/S (PSR)

17.11

Sector: -4.14 Industry: -4.14

P/BV

17.77

Sector: 1.99 Industry: 1.99

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-13.27%

Sector: -64.31% Industry: -64.31%

ROE

-50.24%

Sector: -64.58% Industry: -64.58%

ROIC

-94.49%

Sector: -2,907.20% Industry: -2,907.20%

NET MARGIN

-48.38%

Sector: -39.56% Industry: -39.56%

GROSS MARGIN

100.00%

Sector: 37.04% Industry: 37.04%

OPERATING MARGIN

-35.67%

Sector: -38.54% Industry: -38.54%

EV/EBITDA

-79.15

Sector: -3.94 Industry: -3.94

EV/EBIT

-66.59

Sector: -4.01 Industry: -4.01

PRICE-TO-ASSETS

4.69

Sector: 1.46 Industry: 1.46

BVPS

4.22

Sector: 1.93 Industry: 1.93

EPS

-2.12

Sector: -2.10 Industry: -2.10

EQUITY-TO-ASSETS RATIO

0.26

Sector: 0.43 Industry: 0.43

LIABILITIES / ASSETS

0.74

Sector: 0.40 Industry: 0.40

CAGR REVENUE 5 YEARS

33.92%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

10.46%

Sector: - Industry: -

Fundamentals ARWR

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	26.67	6.91	25.92%	2.23%	$ 561.22 B	21.83%
PFE	19.36	1.60	8.29%	6.75%	$ 145.01 B	11.83%
ABBV	105.03	-57.74	-54.98%	3.12%	$ 381.79 B	5.79%
NVO	10.53	6.36	60.40%	4.15%	$ 199.76 B	37.15%
MRK	33.87	6.59	19.45%	2.71%	$ 302.60 B	13.59%
AZN	27.89	6.11	21.93%	1.71%	$ 289.71 B	17.19%
GILD	18.11	7.12	39.33%	2.37%	$ 166.88 B	30.99%
BMY	16.66	6.03	36.19%	4.20%	$ 121.18 B	15.01%
ZTS	12.98	10.61	81.75%	2.50%	$ 34.32 B	27.79%
REGN	15.02	2.11	14.08%	0.56%	$ 66.44 B	29.65%
HALO	23.11	36.70	158.82%	0.00%	$ 8.06 B	23.13%
AMGN	23.49	19.94	84.87%	2.85%	$ 183.22 B	20.96%
MCK	19.63	-112.06	-570.98%	0.41%	$ 93.46 B	1.18%
HRMY	12.01	1.92	16.00%	0.00%	$ 1.75 B	16.20%
VRTX	25.44	5.70	22.41%	0.00%	$ 110.37 B	35.51%
CAH	30.33	-17.65	-58.20%	1.02%	$ 47.16 B	0.62%
ADMA	11.76	4.98	42.37%	0.00%	$ 1.94 B	32.43%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

ARWR Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (6 people)

United States

37 years

Founded: 1989

1997

Time since IPO - 29 years

232

Employees

Arrowhead Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $10.64 Billions, with shareholders equity totaling $598.92 Millions.

The company employs approximately 232 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Arrowhead Pharmaceuticals Inc. reported $622.01 Millions in revenue, generating net income of $-300.91 Millions.

Key financial metrics include a P/E ratio of -35.37, a price-to-book (P/B) ratio of 17.77, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ARWR.

Market cap

$ 10.64 Billions

Net worth

$ 598.92 Millions

$ 598,920,000.00

Assets

$ 2.27 Billions

$ 2,268,260,000.00

Total Shares Outstanding

142.00 Millions

142,000,000

Average Daily Trading Volume

$ 2.00 Million

$ 1,999,484.00

Sector

Health Care

Industry

Biotechnology

ARWR

ARWR revenue and profits

Financial Results ARWR

DRAG THE FRAME TO SEE MORE DATA

ARWR cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 766.08 7,52% (12M)

P/E

19.63

0.41%

ROE

-570.98%

P/BV

-112.06

CAH - Cardinal Health

$ 200.68 33,22% (12M)

P/E

30.33

1.02%

ROE

-58.20%

P/BV

-17.65

JNJ - Johnson & Johnson

$ 234.34 58,44% (12M)

P/E

26.67

2.23%

ROE

25.92%

P/BV

6.91

MRK - Merck & Co.

$ 122.41 63,49% (12M)

P/E

33.87

2.71%

ROE

19.45%

P/BV

6.59

AZN - AstraZeneca

$ 187.03 34,10% (12M)

P/E

27.89

1.71%

ROE

21.93%

P/BV

6.11

ABBV - AbbVie

$ 215.70 21,44% (12M)

P/E

105.03

3.12%

ROE

-54.98%

P/BV

-57.74

NVO - Novo Nordisk

$ 44.96 --30,01% (12M)

P/E

10.53

4.15%

ROE

60.40%

P/BV

6.36

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 766.08 7,52% (12 M)

P/L

19.63

0.41%

ROE

-570.98%

P/VP

-112.06

CAH - Cardinal Health

$ 200.68 33,22% (12 M)

P/L

30.33

1.02%

ROE

-58.20%

P/VP

-17.65

JNJ - Johnson & Johnson

$ 234.34 58,44% (12 M)

P/L

26.67

2.23%

ROE

25.92%

P/VP

6.91

MRK - Merck & Co.

$ 122.41 63,49% (12 M)

P/L

33.87

2.71%

ROE

19.45%

P/VP

6.59

AZN - AstraZeneca

$ 187.03 34,10% (12 M)

P/L

27.89

1.71%

ROE

21.93%

P/VP

6.11

ABBV - AbbVie

$ 215.70 21,44% (12 M)

P/L

105.03

3.12%

ROE

-54.98%

P/VP

-57.74

NVO - Novo Nordisk

$ 44.96 --30,01% (12 M)

P/L

10.53

4.15%

ROE

60.40%

P/VP

6.36

Frequently Asked Questions

What is the price of Arrowhead Pharmaceuticals (ARWR) today?

The current price of Arrowhead Pharmaceuticals (ARWR) is $ 74.95, representing a 395.37% gain over the past year. The stock began the year trading around $ 66.39 and is currently priced at $ 74.95. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Arrowhead Pharmaceuticals (ARWR) pay dividends?

Arrowhead Pharmaceuticals (ARWR) did not pay dividends over the past year.

Is Arrowhead Pharmaceuticals (ARWR) a good investment?

Arrowhead Pharmaceuticals (ARWR) is currently trading at $ 74.95 with a P/E ratio of -35.37. This represents a -646% premium compared to its historical average P/E. Over the past year, the stock has gained 395.37 and paid $ 0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 395.37%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Arrowhead Pharmaceuticals (ARWR) stock?

You can buy Arrowhead Pharmaceuticals (ARWR) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol ARWR and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Arrowhead Pharmaceuticals (ARWR) yield today?

Over the past month, Arrowhead Pharmaceuticals (ARWR) has returned 1.41% — 395.37% over the past year, and 2.01% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of Arrowhead Pharmaceuticals (ARWR) today at the current price of $ 74.95 your total investment would be $ 7,495.00.

Based on historical performance, the investment would have grown to approximately:

$ 37,127.98 after 1 year
$ 7,645.65 after 5 years
$ 95,373.88 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

ARWR

Arrowhead Pharmaceuticals Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment ARWR

review the fundamentals of Arrowhead Pharmaceuticals shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals Inc.

United States

37 years

1997

232

PROFIT X PRICE ARWR

Financial Results ARWR

ARWR cash flow

Asset, Revenue and Profit Growth - ARWR

ARWR balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

Frequently Asked Questions